Amicus is pioneering next-generation oral therapies for the management of human genetic diseases.
Public (FOLD)
Cranbury, NJ
BiPar is developing a potential new class of tumor-selective drugs designed to meet the unmet needs of cancer patients.
Acquired by Sanofi-aventis (EURONEXT: SAN) (NYSE: SNY)
Calixa is developing hospital-based antibiotics to treat infections resulting from resistant strains of bacteria.
Acquired by Cubist Pharmaceuticals
Cell Pathways is a development-stage pharmaceutical company focused on novel medications to treat and prevent cancer and certain autoimmune diseases.
Public. Acquired by OSI Pharmaceuticals (OSIP)
Centocor revolutionized the science of immunology and has been a leader in the field of cancer and immune-disorders for over 20 years.
Public (CNTO)
Malvern, PA
Cerexa is an innovative biopharmaceutical company focused on developing therapies for the treatment of serious and life–threatening infections.
Acquired by Forest Labs (FRX)
Chimerix develops orally-available, highly potent antiviral drugs for life threatening diseases such as smallpox and HIV.
Private
Durham, NC
CombinatoRx is pioneering the new field of synergistic combination pharmaceuticals to provide a renewable and previously untapped source of novel drug candidates.
Public (CRXX)
Boston, MA
Durata is a biopharmaceutical company pursuing late-stage clinical development of novel antibiotic programs.
Private
New York, NY
Eon Lab is a drug manufacturer that develops, manufactures, and markets a broad range of generic pharmaceutical products.
Public. Acquired by Novartis (NVS)
Esperion is a biopharmaceutical company focused on the discovery and development of therapies for the treatment of cardiovascular disease.
Public. Acquired by Pfizer (PFE)
Personalized medicine through population genomics and informatics.
Public. Acquired by Clinical Data (CLDA)
Liquidia Technologies Inc. is a nanotechnology company that designs and manufactures precisely engineered particles and films for a variety of life and material science applications.
Private
Research Triangle Park, NC
Marinus is creating a new class of neurologic drugs that may revolutionize the treatment of epilepsy in women and infants.
Private
Branford, CT
Matrix Pharmaceutical develops novel local and systemic cancer treatments that may improve or extend the lives of people living with cancer.
Public (MATX)
OraPharma is a specialty pharmaceutical company focused therapeutics for oral health.
Public. Acquired by Johnson & Johnson (JNJ)
ORTHOCON develops bioabsorbable drug delivery products for surgical patients with pain.
Private
North Brunswick, NJ
Peninsula Pharmaceuticals is developing new antibiotic medications to treat life-threatening infections.
Acquired by Johnson & Johnson (JNJ)
Phylogix is an early-stage pharmaceutical company developing chemoprotectant compounds.
Private
Waltham, MA
Pozen is a pharmaceutical company developing therapeutic advancements for treatment of acute migraine.
Public (POZN)
Praecis Pharmaceuticals is a biopharmaceutical company focused on Peptide-based therapeutics that have the potential to address unmet medical needs or improve existing therapies.
Public. Acquired by GlaxoSmithKline (GSK)
Sopherion is a therapeutics platform company initially focused on cancer.
Private
Princeton, NJ
Theraclone Sciences harnesses the power of the human immune system to treat cancer and infectious diseases.
Private
Seattle, WA
Tobira develops novel drugs to help in the treatment of HIV and AIDS.
Private
San Diego, CA
VaxInnate invents vaccines that can be rapidly tailored to treat influenza and major pandemic illnesses.
Private
Cranbury, NJ
